The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Adicet Bio, Inc. | COM NEW | 007002207 | 191,803 | 22,779 | SH | DFND | 1 | 0 | 22,779 | 0 | ||
| Contineum Therapeutics Inc. | CL A | 21217B100 | 22,621,947 | 1,979,173 | SH | DFND | 1 | 0 | 1,979,173 | 0 | ||
| CVRx, Inc. | COM | 126638105 | 28,576,513 | 4,024,861 | SH | DFND | 1 | 0 | 4,024,861 | 0 | ||
| Fate Therapeutics, Inc. | COM | 31189P102 | 3,320,268 | 3,379,064 | SH | DFND | 1 | 0 | 3,379,064 | 0 | ||
| Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 17,709,100 | 814,586 | SH | DFND | 1 | 0 | 814,586 | 0 | ||
| Lyell Immunopharma, Inc. | COM NEW | 55083R203 | 1,689,422 | 54,887 | SH | DFND | 1 | 0 | 54,887 | 0 | ||
| MeiraGTx Holdings plc | COM | G59665102 | 52,796,459 | 6,641,064 | SH | DFND | 1 | 0 | 6,641,064 | 0 | ||
| Nano-X Imaging Ltd. | ORD SHS | M70700105 | 444,786 | 158,852 | SH | DFND | 1 | 0 | 158,852 | 0 | ||
| Nanobiotix S.A. | SPONSORED ADS | 63009J107 | 130,022,626 | 5,623,816 | SH | DFND | 1 | 0 | 5,623,816 | 0 | ||
| Neumora Therapeutics, Inc. | COM | 640979100 | 3,310,507 | 1,849,445 | SH | DFND | 1 | 0 | 1,849,445 | 0 | ||
| Procept BioRobotics Corporation | COM | 74276L105 | 11,260,761 | 357,939 | SH | DFND | 1 | 0 | 357,939 | 0 | ||
| Protagonist Therapeutics Inc. | COM | 74366E102 | 213,911,643 | 2,449,183 | SH | DFND | 1 | 0 | 2,449,183 | 0 | ||
| Rallybio Corporation | COM | 75120L100 | 2,494,909 | 3,636,363 | SH | DFND | 1 | 0 | 3,636,363 | 0 | ||
| Rapport Therapeutics, Inc. | COM | 75383L102 | 54,142,246 | 1,784,517 | SH | DFND | 1 | 0 | 1,784,517 | 0 | ||
| Vor Biopharma, Inc. | COM NEW | 929033207 | 702,815 | 53,732 | SH | DFND | 1 | 0 | 53,732 | 0 | ||
| Xencor, Inc. | COM | 98401F105 | 11,452,829 | 748,062 | SH | DFND | 1 | 0 | 748,062 | 0 | ||
| Standard BioTools, Inc. | COM | 34385P108 | 399,318 | 311,967 | SH | DFND | 0 | 311,967 | 0 | |||